Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001013762-25-004139
Filing Date
2025-03-28
Accepted
2025-03-28 16:28:40
Documents
71
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0234891-10k_silopharma.htm   iXBRL 10-K 1328531
2 DESCRIPTION OF THE REGISTRANT'S SECURITIES ea023489101ex4-1_silopharma.htm EX-4.1 20804
3 INSIDER TRADING POLICY ea023489101ex19-1_silopharma.htm EX-19.1 129929
4 CONSENT OF SALBERG & COMPANY, P.A. ea023489101ex23-1_silopharma.htm EX-23.1 1874
5 CERTIFICATION ea023489101ex31-1_silopharma.htm EX-31.1 11733
6 CERTIFICATION ea023489101ex31-2_silopharma.htm EX-31.2 11606
7 CERTIFICATION ea023489101ex32-1_silopharma.htm EX-32.1 5184
8 GRAPHIC image_001.jpg GRAPHIC 99918
9 GRAPHIC fin_001.jpg GRAPHIC 8440
  Complete submission text file 0001013762-25-004139.txt   6713940

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE silo-20241231.xsd EX-101.SCH 58221
11 XBRL CALCULATION FILE silo-20241231_cal.xml EX-101.CAL 42123
12 XBRL DEFINITION FILE silo-20241231_def.xml EX-101.DEF 261664
13 XBRL LABEL FILE silo-20241231_lab.xml EX-101.LAB 568155
14 XBRL PRESENTATION FILE silo-20241231_pre.xml EX-101.PRE 290328
73 EXTRACTED XBRL INSTANCE DOCUMENT ea0234891-10k_silopharma_htm.xml XML 499615
Mailing Address 677 N. WASHINGTON BLVD SARASOTA FL 34236
Business Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

EIN.: 462137136 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41512 | Film No.: 25786794
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)